SCHEMBL1754124

SCHEMBL1754124

Cc1cc([C@@H](C)N)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.50
▸ TDP1 Q9NUW8 5/20 0.48
▸ TP53 P04637 1/20 0.48
▸ KDM4E B2RXH2 5/20 0.47
▸ RECQL P46063 4/20 0.47
▸ MAPT P10636 4/20 0.47
▸ HIF1A Q16665 3/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ THPO P40225 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ APEX1 P27695 1/20 0.47
▸ MTOR P42345 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ TRPA1 O75762 1/20 0.47
▸ PTGS1 P23219 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371198 0.83 TRPA1 (0.69) TDP1KDM4ERECQLMAPTHIF1A
SCHEMBL29657745 0.82 TDP1 (0.52) PDE10ATDP1TP53KDM4ERECQL
SCHEMBL30516160 0.82 TDP1 (0.67) TDP1KDM4ERECQLMAPTHIF1A
SCHEMBL28878142 0.82 TDP1 (0.52) PDE10ATDP1TP53KDM4ERECQL
SCHEMBL278495 0.82 TDP1 (0.67) TDP1KDM4ERECQLMAPTHIF1A
SCHEMBL14293022 0.82 TDP1 (0.67) TDP1KDM4ERECQLMAPTHIF1A
SCHEMBL29948126 0.82 TDP1 (0.52) PDE10ATDP1TP53KDM4ERECQL
SCHEMBL921090 0.82 TDP1 (0.52) PDE10ATDP1TP53KDM4ERECQL
SCHEMBL1397101 0.82 PTGS1 (0.68) PDE10ATDP1TP53KDM4ERECQL
SCHEMBL7309494 0.82 KDM4E (0.72) PDE10ATDP1TP53KDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 — — US disclosed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS TRPV1, P2RY1, TRPV2 PDE10A 1360/4885TDP1 1923/4885TP53 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback